The patients with higher FAK expression in primary tumors expressed higher expression of FAK in metastatic tumors (Figure 3B).Moreover, we performed correlation analysis of FAK expression in matched primary and metastatic tumors with progression free survival (PFS) and overall survival (OS). Here, PTK2 is linked to metastatic neoplasm.